Abstract:Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in high-risk patients with isolated or concomitant tricuspid regurgitation. The development of new minimally invasive solutions potentially more adapted to this largely undertreated population of patients, has fuelled the interest for the tricuspid valve. Growing evidence and new concepts have contributed to revise obsolete and misleading perceptions around the right side of the heart. New definitions, classifications, and a better understanding of the disease pathophysiology and phenotypes, as well as their associated patient journeys have profoundly and durably changed the landscape of tricuspid disease. A number of registries and a recent randomized controlled pivotal trial provide preliminary guidance for decision-making. TTVI seem to be very safe and effective in selected patients, although clinical benefits beyond improved quality of life remain to be demonstrated. Even if more efforts are needed, increased disease awareness is gaining momentum in the community and supports the establishment of dedicated expert valve centres. This review is summarizing the achievements in the field and provides perspectives for a less invasive management of a no-more-forgotten disease. Disease stage and therapeutic strategies for tricuspid regurgitation. Tricuspid regurgitation evolves from undetectable early forms to advanced stages characterized by escalating symptoms, right heart failure, and organ impairment. While medical therapy is utilized throughout the disease course, its effectiveness wanes with progression. Surgery can play a role in the earlier stages, while transcatheter therapies are available for patients at high risk and in the more advanced stages of disease. Significant overlap between treatment options underscores the urgent need for precise, evidence-based protocols. Overall, early intervention is crucial to prevent organ damage and avoid futility of late treatments (smileys becoming sad). CAVI, caval valve implantation; RHF, right heart failure; TR, tricuspid regurgitation; RA, right atrial; RV, right ventricular; TTV, transcatheter tricuspid valve.

Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions

Multimodality Imaging for Transcatheter Tricuspid Regurgitation Interventions: Novel Approaches to the Forgotten Valve

Multimodality Imaging in the Management of Tricuspid Valve Regurgitation

Multimodality Imaging Approach for Planning and Guiding Direct Transcatheter Tricuspid Valve Annuloplasty.

Device and Patient Selection

Utility of CT and MRI in Tricuspid Valve Interventions.

Transcatheter treatment of the tricuspid valve: current status and perspectives

Imaging and guiding intervention for tricuspid valve disorders using 3-dimensional transesophageal echocardiography in pediatric and congenital heart disease

Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions

Multi-Modality Imaging in the Evaluation and Treatment of Tricuspid Regurgitation

The Current Landscape of Transcatheter Tricuspid Valve Intervention

New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation

Tricuspid Valve Imaging and Right Ventricular Function Analysis Using Cardiac CT and MRI

Transcatheter tricuspid valve intervention: a practical algorithm for patient selection

Multimodality imaging to guide transcatheter treatment of severe degenerative tricuspid regurgitation with tricuspid valve‐in‐ring implantation and paravalvular leak closure

Pretranscatheter and Posttranscatheter Valve Planning with Computed Tomography

Transcatheter tricuspid valve interventions: Current status and future perspectives

Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?

Imaging for Native Mitral Valve Surgical and Transcatheter Interventions

Key Echocardiographic Considerations for Tricuspid Valve Transcatheter Edge-to-Edge Repair.